Oncolytics Biotech Inc.

NASDAQ:ONCY

1.07 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Operating Activities:
Net Income -27.752-24.835-26.304-22.505-33.123-17.037-15.617-15.14-13.723-18.619-23.533-36.374-29.045-19.974-16.996-17.55-15.642-14.298-12.782-12.956-8.544-6.091-6.171-3.613-0.574
Depreciation & Amortization 0.4030.3920.4520.4460.4860.0950.0910.1620.180.1640.1320.1090.0930.0630.2570.411.0030.9270.8560.7520.6640.5740.4650.2050.002
Deferred Income Tax -2.36800.409-2.84712.962-0.3740-0.546-1.246-0.738-0.514-0.641019.9740-0.06400000-0.648-0.341-0.1270
Stock Based Compensation 2.0682.3783.8262.5591.471.4160.5790.4060.430.980.4240.7311.8063.2510.4440.064000000000
Change In Working Capital 1.7650.391-0.9080.21-1.7963.9040.1812.234-1.105-2.444-1.3741.1883.791-1.718-0.6421.7870.530.7890.585-0.069-0.486-1.1241.7740.3770.038
Accounts Receivables 0.5060.345-0.7761.979-2.0174.767-4.7670.286-0.148-0.086-0.0610.010.23-0.220.022-0.006000000000
Inventory 0000000000000000000000000
Accounts Payables 0000000000000000000000000
Other Working Capital 1.2590.046-0.132-1.7690.221-0.8634.9481.948-0.957-2.358-1.3131.1783.561-1.498-0.6641.7940.530.7890.585-0.069-0.486-1.1241.7740.3770.038
Other Non Cash Items -2.564-1.6810.0920.0690.0950.076-0.1250.4060.430.980.4240.7310.815-19.630.1160.0640.5390.4260.2893.0482.889-0000
Operating Cash Flow -28.448-23.355-22.434-22.068-19.906-11.92-14.891-12.478-15.035-19.677-24.441-34.256-22.541-18.034-16.82-15.289-13.57-12.155-11.052-9.225-5.478-7.256-4.273-3.158-0.534
Investing Activities:
Investments In Property Plant And Equipment -0.008-0.055-0.286-0.029-0.011-0.107-0.106-0.024-0.108-0.153-0.255-0.126-0.258-0.134-0.01-0.112-0.945-0.036-0.061-0.974-1.097-1.052-0.586-0.049-0.02
Acquisitions Net 000000000000000-4,678.785000000000
Purchases Of Investments 0-20.34800000-0.028-0.02900-0.0320-1.929-1.759-0.348-0.949-1.035-22.195-6.777-18.1120000
Sales Maturities Of Investments 20.23000002.089000001.67206.122136.57313.8086.6573.11400000
Other Investing Activites 0.02-0.0200002.089-0-0-0.03-0.032-000-04,678.7850-0.843-1.0250.1343.003-0.1470-0.324-0.05
Investing Cash Flow 20.222-20.403-0.286-0.029-0.011-0.1071.983-0.051-0.138-0.183-0.287-0.1591.415-2.0634.35312.5414.67911.894-16.625-4.504-16.205-1.2-0.586-0.373-0.07
Financing Activities:
Debt Repayment -0.407-0.381-0.366-0.461-0.44700000000000000000000
Common Stock Issued 32.40112.57432.91238.29617.99713.17412.4690.95623.6689.04430.21919.764026.7620.9873.42112.1140.24118.788.1210.7010.0342.2113.6023.097
Common Stock Repurchased 0000000000000000000000000
Dividends Paid 0000000000000000000000000
Other Financing Activities 0.0320.0120.4691.9383.4660.1250.3430.9560.0240.0090.1791.08514.8250.52817.8120.04200015.37515.3041.7702.9992.055
Financing Cash Flow 31.99412.20533.01639.77421.01613.29912.8130.95623.6689.04430.39820.84914.82527.28838.7983.46312.1140.24118.7823.49616.0051.8042.2116.6015.152
Other Information:
Effect Of Forex Changes On Cash -0.5221.957-0.253-0.605-0.650.592-0.103-0.4091.368-0.2520.227-0.03-0.076-0.344-0.133000-0000000
Net Change In Cash 22.033-29.59610.04217.0720.4481.864-0.198-11.9829.863-11.0685.897-13.595-6.3786.84826.1970.7153.224-0.02-8.8979.767-5.678-6.652-2.64813.074.548
Cash At End Of Period 31.53411.66641.26231.2214.14813.711.83612.03424.01614.15325.2219.32432.91939.29733.9777.436.7153.4923.51112.4092.6418.31914.97117.6194.549